Early research (Phase 1)UnknownNCT06233201What this trial is testingSitagliptin and Metformin Hydrochloride Tablets 50 mg/500 mg Relative to OriginatorWho this might be right forHealthy Subjects Bio-innova Co., Ltd 34
Post-approval studies (Phase 4)Study completedNCT06613750What this trial is testingComparative Study of Sitagliptin and Gliclazide With Metformin in Type 2 Diabetes Patients With GlucotoxicityWho this might be right forType 2 Diabetes MellitusGlucotoxicity Zhibin Xu 129
Large-scale testing (Phase 3)Study completedNCT01137812What this trial is testingThe CANTATA-D2 Trial (CANagliflozin Treatment And Trial Analysis - DPP-4 Inhibitor Second Comparator Trial)Who this might be right forDiabetes Mellitus, Type 2 Janssen Research & Development, LLC 756
Large-scale testing (Phase 3)Ended earlyNCT01678820What this trial is testingThe Efficacy and Safety of MK-0431D (a Fixed-dose Combination of Sitagliptin and Simvastatin) for the Treatment of Participants With Type 2 Diabetes Mellitus (T2DM) With Inadequate Glycemic Control on Metformin Monotherapy (MK-0431D-266)Who this might be right forType 2 Diabetes Mellitus Merck Sharp & Dohme LLC 299
Post-approval studies (Phase 4)Study completedNCT01341717What this trial is testingEffects of Sitagliptin on Type 2 Diabetes Mellitus Patients on Treatment With Metformin and InsulinWho this might be right forDiabetes Mellitus, Type 2 Jothydev's Diabetes and Research Centre 440
Post-approval studies (Phase 4)Study completedNCT02256189What this trial is testingSitagliptin and Glucagon CounterregulationWho this might be right forType 2 Diabetes Lund University 28
Large-scale testing (Phase 3)WithdrawnNCT01984606What this trial is testingEfficacy and Safety of Empagliflozin Versus Sitagliptin in Patients With Type 2 DiabetesWho this might be right forDiabetes Mellitus, Type 2 Boehringer Ingelheim
Testing effectiveness (Phase 2)Study completedNCT01119846What this trial is testingA Study in Type 2 Diabetics of Single and Multiple Doses of Orally Administered GSK1292263 to Investigate the Safety, Tolerability, Pharmacokinetics and PharmacodynamicsWho this might be right forDiabetes Mellitus, Type 2 GlaxoSmithKline 100
Early research (Phase 1)Study completedNCT04877106What this trial is testingBioequivalence of Sitagliptin Phosphate/Metformin Hydrochloride Tablets in Healthy Chinese SubjectsWho this might be right forHealthy Subjects The Affiliated Hospital of Qingdao University 48
Post-approval studies (Phase 4)Study completedNCT01269996What this trial is testingJanUmet Before Insulin Lantus In Eastern Population Evaluation Program (JUBILEE) In Type 2 Diabetic PatientsWho this might be right forType 2 Diabetes Mellitus Chinese University of Hong Kong 71
Post-approval studies (Phase 4)Study completedNCT01718093What this trial is testingA Pilot Study to Assess the Glucose Lowering Effect of Metformin and Sitagliptin in Adolescents With Type 1 DiabetesWho this might be right forType 1 Diabetes Baylor College of Medicine 21
Testing effectiveness (Phase 2)Study completedNCT01376323What this trial is testingGSK256073 in Subjects With Type 2 Diabetes Mellitus Who Are Being Treated With MetforminWho this might be right forDiabetes Mellitus, Type 2 GlaxoSmithKline 92
Post-approval studies (Phase 4)Study completedNCT02008682What this trial is testingThe Efficacy and Safety of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin in Chinese Subjects With Type 2 DiabetesWho this might be right forDiabetesDiabetes Mellitus, Type 2 Novo Nordisk A/S 368
Not applicableUnknownNCT01341795What this trial is testingGenetic Variation in the Transporters and Hypoglycemic AgentsWho this might be right forType 2 Diabetes Ajou University School of Medicine 100
Early research (Phase 1)Study completedNCT02956044What this trial is testingInteraction of Bexagliflozin With Metformin, Glimepiride and SitagliptinWho this might be right forType2 Diabetes Mellitus Theracos 54
Large-scale testing (Phase 3)Ended earlyNCT01834274What this trial is testingComparison of Fasiglifam (TAK-875) With Sitagliptin When Used in Combination With Metformin in Patients With Type 2 DiabetesWho this might be right forDiabetes Mellitus, Type 2 Takeda 96
Early research (Phase 1)Study completedNCT01933672What this trial is testingStudy Of Two Dosing Regimens Of PF-04937319 Compared To An Approved Agent (Sitagliptin) In Patients With Type 2 DiabetesWho this might be right forType 2 Diabetes Mellitus Pfizer 33
Large-scale testing (Phase 3)Study completedNCT01462266What this trial is testingStudy of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260)Who this might be right forType 2 Diabetes Mellitus Merck Sharp & Dohme LLC 660
Large-scale testing (Phase 3)Study completedNCT01034111What this trial is testingA Local Experiential Study With Sitagliptin (an Antihyperglycemic Drug) in 30 Patients With Type 2 Diabetes Mellitus (0431-178)Who this might be right forType 2 Diabetes Merck Sharp & Dohme LLC 30
Large-scale testing (Phase 3)Study completedNCT00875394What this trial is testingStudy to Assess the Efficacy and Safety of Sitagliptin Added to the Regimen of Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (0431-189)Who this might be right forDiabetes Mellitus, Non-Insulin-Dependent Merck Sharp & Dohme LLC 68